The story · written by deepseek-v4.1-flash,
Israel’s medical cannabis programme did not begin with a law. It began with case-by-case approvals in 1992, mostly for palliative cancer patients, and grew into a licensing system that by 2026 served 145,758 people.[1][2]
From exceptions to a programme
For the first decade and a half, the health ministry approved individual patients and a small number of growers. By 2007 it was licensing patients and growers on a regular basis, and the programme began to look like a national system rather than a series of exceptions.[1]
The turning point was administrative rather than legislative. In 2011 the government gave the Medical Cannabis Unit responsibility for oversight, and the number of approved patients rose from 3,097 that April to 140,483 in January 2024.[1] The 2007 entry marks the start of regular licensing.
What the programme covers
The programme is broad by international standards. Procedure 106 sets clinical guidance, a starting dose of about 20 g a month and a higher approval threshold for 100 g or more.[3] It also states that cannabis is not a registered medicine and that its efficacy and safety have not been proven.[3] Patients receive flower or oil through licensed pharmacies; flower was 94% of approved products by March 2025.[1]
In April 2024 the ministry moved ten indications to health-fund prescriptions, capped at 60 g a month. Chronic non-cancer pain and PTSD, the two largest categories, stayed under Medical Cannabis Unit licences rather than the prescription route.[1]
A record, then a debate
Active licences and prescriptions fell 7.5% from January 2024 to March 2025, the first decline since 2011, then recovered to 145,758 in June 2026. The programme’s size and its research base made Israel a reference case for other health systems.[1][2] In May 2026 a health ministry committee recommended phasing out smoked medical cannabis and moving prescribing to the health funds; the health minister froze the recommendations three days later.[1]
The Israel profile sets out the current prescription rules, the licence categories and the criminal penalties that still apply outside the medical system.
Score by segment 0 to 10
- Possession · 25%2 → 2
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%3 → 3
- Sharing & gifting · 10%1 → 1
- Consumption · 10%2 → 2
- Legal access · 10%0 → 3+3
The bar shows the score after the change; the tick marks where it stood before. Israel's scores have changed again since.
References
- Aviram — Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011–2025archived
- Israel Ministry of Health — Medical Cannabis Unit report, June 2026archived
- Israel Ministry of Health — Procedure 106, medical cannabis, update 7 (January 2024)archived
- Wikipedia — Cannabis in Israelarchived
- The Algemeiner — In Israel, Medical Marijuana Research Far From Stuck in the Weedsarchived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.